JPRN-UMIN000005186招募中未知
A randomized, double-blind, placebo-controlled, crossover trial of D-cycloserine in schizophrenic patients - A double-blind, placebo-controlled, crossover trial of D-cycloserine in schizophrenic patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who meet the following criteria should be excluded: 1) under being treated with the structured psychotherapies or cognitive-behavioral therapies within 12 weeks before the beginning of this study; 2) DSM-IV diagnosis of substance-related disorders within 24 weeks before the beginning of this study; 3) under being treated with the electroconvulsive therapy within 12 weeks before the beginning of this study; 4) during pregnancy and lactation or the possible pregnancy within 30 days after the end of this study; 5) suicide attempt within 24 weeks before the beginning of this study; 6) history or complication of convulsive disorders; 7) history of hypersensitivity to D-cycloserine or lactose; 8) complication of serious organic brain diseases; 9) complication of serious somatic disorders including hepatopathy, nephropathy, cardiopathy, etc.; 10) implantation of metal materials in the body; 11) insertion of a cardiac pacemaker; 12) under being treated with D-cycloserine; 13) other conditions that are considered to be inappropriate to the present trial by its investigators.
研究者
相似试验
已完成
不适用
A randomized, double-blind, placebo-controlled, crossover study on the suppressive effect of the peptide on postprandial blood glucose levelot applicableJPRN-UMIN000048002CPCC Company Limited30
已完成
1 期
A study to evaluate the prebiotic effect of Manuka Honey with Cyclopower (Trademark) capsules in healthy subjects.Gastrointestinal effect and wellnessAlternative and Complementary Medicine - Other alternative and complementary medicineOral and Gastrointestinal - Normal oral and gastrointestinal development and functionACTRN12615000857505The New Zealand Institute for Plant and Food Research20
进行中（未招募）
不适用
A study assessing the safety, tolerability and efficacy of a new medication (SER100) in patients with Isolated Systolic Hypertension (ISH) insufficiently treated with 1-3 other anti-hypertensives.MedDRA version: 14.1Level: LLTClassification code 10050591Term: Isolated systolic hypertensionSystem Organ Class: 100000004866Isolated Systolic HypertensionEUCTR2013-001227-40-HUSerodus ASA30
已完成
Unknown
A clinical trial assessing the efficacy and safety of DA-5521 in treating hangoversKCT0008927Dong-A Pharm24
进行中（未招募）
1 期
Multi-center trial in healthy subjects to investigate the effects of analgesic drugs on pain processing observed by electroencephalography (EEG)Healthy volunteers (intended indication: pain)MedDRA version: 20.0Level: PTClassification code 10033371Term: PainSystem Organ Class: 10018065 - General disorders and administration site conditionsEUCTR2019-001204-37-ITMBERTO I - POLICLINICO DI ROMA56